Lundbeck Unveils Depression Education Program In China
This article was originally published in PharmAsia News
Healthcare experts estimate a large share of China’s depression population has never been diagnosed thanks to low recognition of the disease, creating a potentially huge population of patients who could benefit from treatment.
You may also be interested in...
China’s Simcere Receives Buyout Offer From Its Chairman, But Could Delisting Be A Negative Overseas?
Simcere would join Chinese firms 3SBio and ShangPharma in pulling out of the U.S. stock market.
The Ministry of Health’s GSP regulation tries to plug a hole in supply chain security through tighter IT controls, such as requiring electronic barcodes.